The IL-1β Receptor Antagonist SER140 Postpones the Onset of Diabetes in Female Nonobese Diabetic Mice

The cytokine interleukin-1β (IL-1β) is known to stimulate proinflammatory immune responses and impair β-cell function and viability, all critical events in the pathogenesis of type 1 diabetes (T1D). Here we evaluate the effect of SER140, a small peptide IL-1β receptor antagonist, on diabetes progres...

Descripción completa

Detalles Bibliográficos
Autores principales: Cucak, Helena, Hansen, Gitte, Vrang, Niels, Skarsfeldt, Torben, Steiness, Eva, Jelsing, Jacob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4756207/
https://www.ncbi.nlm.nih.gov/pubmed/26953152
http://dx.doi.org/10.1155/2016/7484601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4756207/
https://www.ncbi.nlm.nih.gov/pubmed/26953152
http://dx.doi.org/10.1155/2016/7484601

Ejemplares similares